Growth sensitivity also correlated with altered mRNA expression of transcripts known to be associated with a MEK-dependence signature in melanoma and other ERK-dependent tumors.30,31 Changes in expression of this signature may be a useful predictive biomarker for clinical responses, but will need to be validated in patient-derived xenograft models and prospective human trials. The gene discussed is MAP2K7; the disease is melanoma.